Archives

by in
Entry Author Date Location
Intrigue and Outdated Rules Complicate Big Biotech Patent Fight 12/16/14 National
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
After Unlikely Idenix Sale, Renaud Jumps to RaNA to Outfox Junk DNA 12/01/14 Boston
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
East Coast Biotech Roundup: Regeneron, Sage, Tara, Alnylam, & More 11/14/14 Boston
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
With $24M and Pharma Backing, Ex Epizyme Prez Aims to “Raze” Tumors 10/14/14 Boston
Well-Traveled Rhodes Leaves Epizyme For Atlas Venture Partnership 09/29/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
To Fight Cramps, Christoph Westphal Taps Boston All-Stars for $40M 09/09/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
Which Countries Excel in Creating New Drugs? It’s Complicated 09/02/14 Seattle
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
7 Takeaways From “What’s Hot in Boston Biotech” 04/22/14 Boston
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
What’s Hot in Boston Biotech: Here’s the Agenda for April 16 03/27/14 Boston
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy 02/12/14 Boston
Hunting For Brain Plaques, Neurophage Turns to a Virus 01/31/14 Boston
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday 01/29/14 Boston
San Diego Life Sciences Roundup: Isis, Receptos, Suneva, and More 01/17/14 San Diego
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Moderna, Living a Charmed Life, Pulls in Another $125M From Alexion 01/13/14 Boston
Alnylam Wheels, Deals, and Gets $700M Investment From Genzyme 01/13/14 Boston
Dicerna Joins Biotech IPO Queue, Plans $69M Raise 01/02/14 Boston
Arrowhead Picks Up Where Roche Left Off, Jumps Ahead in RNAi 12/20/13 Wisconsin
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
Page 1 of 9 next page »